BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3512180)

  • 1. Psoralen photochemotherapy--mechanisms, drugs, toxicity.
    Hönigsmann H
    Curr Probl Dermatol; 1986; 15():52-66. PubMed ID: 3512180
    [No Abstract]   [Full Text] [Related]  

  • 2. Skin photosensitizing and Langerhans' cell depleting activity of topical (bath) PUVA therapy: comparison of trimethylpsoralen and 8-methoxypsoralen.
    Koulu L; Jansén CT
    Acta Derm Venereol; 1983; 63(2):137-41. PubMed ID: 6189328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PUVA therapy for polymorphous light eruptions: comparison of systemic methoxsalen and topical trioxsalen regimens and evaluation of local protective mechanisms.
    Jansén CT; Karvonen J; Malmiharju T
    Acta Derm Venereol; 1982; 62(4):317-20. PubMed ID: 6183864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PUVA and the induction of skin cancer.
    Stern RS
    Carcinog Compr Surv; 1989; 11():85-101. PubMed ID: 2646023
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term risks of psoralen and UV-A therapy for psoriasis.
    Farber EM; Abel EA; Cox AJ
    Arch Dermatol; 1983 May; 119(5):426-31. PubMed ID: 6342539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultraviolet A phototherapy and trimethylpsoralen UVA photochemotherapy in polymorphous light eruption--a controlled study.
    Berg M; Ros AM; Berne B
    Photodermatol Photoimmunol Photomed; 1994 Aug; 10(4):139-43. PubMed ID: 7803223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous phototoxicity due to psoralens.
    Gange RW; Parrish JA
    Natl Cancer Inst Monogr; 1984 Dec; 66():117-26. PubMed ID: 6531018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5',8-trimethylpsoralen, and psoralen in vitiligo.
    Pathak MA; Mosher DB; Fitzpatrick TB
    Natl Cancer Inst Monogr; 1984 Dec; 66():165-73. PubMed ID: 6531024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nature and molecular basis of cutaneous photosensitivity reactions to psoralens and coal tar.
    Pathak MA; Joshi PC
    J Invest Dermatol; 1983 Jun; 80 Suppl():66s-74s. PubMed ID: 6854058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Photochemotherapy--psoralen + UV-A (PUVA)--increased risk of cancer?].
    Harnes DK; Thune P
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):200-1. PubMed ID: 8430401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
    Berne B; Fischer T; Michaëlsson G; Norén P
    Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Unusual adverse effects of oral photochemotherapy (PUVA-therapy) in psoriasis].
    Hofmann C; Plewig G; Braun-Falco O
    Hautarzt; 1977 Nov; 28(11):583-8. PubMed ID: 599020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin pigmentation as a predictor of minimal phototoxic dose after oral methoxsalen.
    Bech-Thomsen N; Angelo HR; Wulf HC
    Arch Dermatol; 1994 Apr; 130(4):464-8. PubMed ID: 8166483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of psoralen photosensitization reactions.
    Pathak MA
    Natl Cancer Inst Monogr; 1984 Dec; 66():41-6. PubMed ID: 6531038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoralens in photochemotherapy of skin diseases.
    Pathak MA; Parrish JA; Fitzpatrick TB
    Farmaco Sci; 1981 Jul; 36(7):479-91. PubMed ID: 7274436
    [No Abstract]   [Full Text] [Related]  

  • 16. PUVA treatment and skin cancer: A follow-up study.
    Lassus A; Reunala T; Idänpää-Heikkilä J; Juvakoski T; Salo O
    Acta Derm Venereol; 1981; 61(2):141-5. PubMed ID: 6165190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultraviolet-induced pigmentary changes: benefits and hazards.
    Fitzpatrick TB
    Curr Probl Dermatol; 1986; 15():25-38. PubMed ID: 3512179
    [No Abstract]   [Full Text] [Related]  

  • 18. [Patient education. Information letter on PUVA phototherapy].
    Groupe de recherche sur psoriasis de Société française de dermatologie, mai 2011
    Ann Dermatol Venereol; 2011 Dec; 138(12):859-60. PubMed ID: 22137630
    [No Abstract]   [Full Text] [Related]  

  • 19. [Problems posed by the therapeutic use of photosensitizers in dermatology].
    Beani JC; Amblard P; Reymond JL
    Biochimie; 1986 Jun; 68(6):905-12. PubMed ID: 2944547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic toxicity of psoralen and ultraviolet radiation in human cells.
    Bredberg A
    Acta Derm Venereol Suppl (Stockh); 1982; 104():1-40. PubMed ID: 6961722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.